Patient-Specific BBB, Built for Precision.
We deliver high-throughput, iPSC-derived BBB assembloids built on 10+ years of scientific rigor and published academic research. Our modular, reproducible assays adapt to your therapeutic area — bringing human-relevant insight directly into your CNS pipeline. Every study is executed exclusively by our expert scientific team, ensuring the highest QC standards and data reliability.
Have a CNS project in mind? Contact our team to discuss study design, timelines and how NeuroSkye can support your BBB needs.
Not Just Permeability. We Provide Predictability
NeuroSkye delivers robustly validated, mechanistically predictive BBB data through our rigorously standardized human assembloid workflows. We reveal not just whether molecules cross — but how and why — empowering confident and faster selection of CNS therapeutics.
Your Gateway Through the BBB.
Traditional CNS models fall short in replicating the full complexity of the human BBB. NeuroSkye’s human BBB assembloids deliver barrier insight and predictive power — combining high throughput scalability (thousands of uniform assembloids produced at a time), >98% reproducibility, and NAM-aligned workflows at low cost.
Built for the Future of Drug Development.
NeuroSkye’s New Approach Methodologies (NAMs) support ethical, human-relevant and regulation-ready drug development for CNS, oncology, neuroinflammation and beyond.
Less Guesswork. More Go/No-Go Confidence.
Our BBB platforms are already helping teams make smarter and faster decisions. From brain cancer to neurodegeneration diseases, our modular systems are adaptable, scalable and ready to transform CNS discovery.
